Diabetes is the major cause of end-stage renal disease (ESRD) and chronic kidney disease (CKD) and with the increasing prevalence of diabetes worldwide the incidence rate of ESRD and CKD is increasing gradually. According to Centers for Disease Control and Prevention (CDC), 113,136 patients initiated the treatment for ESRD through dialysis and kidney transplantation in the U.S. in 2011, among which diabetes was responsible for ESRD in 44% of the patients. The CDC statistics also revealed that the number of diabetic patients suffering from ESRD is constantly increasing, as there were 48,374 diabetic ESRD patients in 2008 in U.S., which has increased to 49,800 in 2011. Rise in the diabetic ESRD patients has increased the use of dialysis products and services, leading to growth of the market.
Download Exclusive Sample of this report: https://goo.gl/YmTwpK
Increasing prevalence of diabetes globally will result in higher incidence of CKD and ESRD, which will fuel the growth of the dialysis products and services market during the forecast period. According to the International Diabetes Federation’s (IDF) 2013 report, 381.8 million people in the world had diabetes in 2013, with most of them aged between 40 and 59. Around 80% of this population lives in the low and middle income countries. IDF also suggested that China and India are the top two countries with highest diabetes prevalence in people aged between 20 and 79 years, globally. China was at the top, with the diabetes population increasing from 92.3 million in 2012 to 98.4 million in 2013. India was ranked second with the diabetes population increasing from 63 million in 2012 to 65.1 million in 2013. Moreover, more than 50% of the population is reported to be undiagnosed in these regions. Increasing prevalence of diabetes in Asia Pacific countries will lead to higher incidence of CKD and ESRD, which makes the Asia Pacific region most opportunistic market for dialysis products and services. Diabetes prevalence is also increasing in developed regions of North America and Europe. Diabetes UK statistics illustrate that the prevalence of diabetes has increased from 1.4 million people in 1996 to 2.7 million in 2013. Moreover, it is predicted by Diabetes UK that this number would increase to 4 million by 2025. Drastic increase in the percentage of diabetic patients worldwide would lead to higher incidence of ESRD and CKD, which will drive the dialysis products and services market during the forecast period.
Increasing prevalence of diabetes which will result in higher incidence of ESRD and CKD in both developing and developed countries will drive the global dialysis products and services market, as suggested by market research report published by Transparency Market Research (http://www.transparencymarketresearch.com/), a U.S. based market research firm. According to its estimates, the global dialysis products and services market is expected to grow at a CAGR of 5.9% from 2014 to 2020. This report provides market size and forecast for dialysis products and services based on hemodialysis (HD) and peritoneal dialysis (PD) product segments and different dialysis services. HD products have been segmented into five segments including dialysis machine, dialyzer access products or catheters, bloodlines, concentrates and others (water treatment system and fistula needles). PD dialysis products include four segments namely concentrates or dialysate, PD machines, catheters and transfer sets. Services segment of the report includes the market analysis for in-center dialysis and home dialysis.
Browse full Dialysis Products and Services Market report with complete TOC at http://www.transparencymarketresearch.com/dialysis-products-services-market.html
According to the study, HD machines among HD products and concentrates or dialysate among PD products are the fastest growing segments for period of 2014 to 2020. Among services, home dialysis services are expected to grow at faster pace. Introduction of continuous ambulatory peritoneal dialysis (CAPD) and growing trend of home hemodialysis services by in-centers are assisting the growth of home dialysis services. However, majority share of the total services will be held by in-center dialysis as they provide hemodialysis services and it is one of the oldest and most preferred method of dialysis.
Asahi Kasei Corporation, Baxter International, Inc., B. Braun Melsungen AG, Cantel Medical Corporation, NxStage Medical, Inc. Covidien plc, C.R. Bard, Inc., Fresenius SE & Co. KGaA, Kawasumi Laboratories, Inc., Medical Components, Inc., Nikkiso Co., Ltd., DaVita Healthcare Partners, Inc., Nipro Corporation, and Rockwell Medical Technologies, Inc. are some of the major companies in the global dialysis products and services market, highlighted in the report.